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Three lipid A derivatives (hexaacyl monophosphoryl lipid A, hexaacyl diphosphoryl ipid A, and disacchar- 
ide precursor IVA) were shown to activate protein kinase C from rabbit brain. These derivatives ubstituted 
for phosphatidylserine in a concentration-dependent manner and did not compete for binding of 
[3H]phorbol dibutyrate to its receptor site. Instead, phorbol dibutyrate binding was increased on raising 
the concentration of the derivatives in a similar manner to phosphatidylserine. The phorbol ester 12-O-tetra- 
decanol 13-acetate augmented the activation of protein kinase C by the lipid A derivatives. 
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1. INTRODUCTION 
Lipopolysaccharide (LPS) is a prominent and 
complex molecule of the outer surface of the outer 
membrane of gram-negative bacteria [l]. LPS in- 
itiates many effects on cells of the immune system 
such as stimulation of B lymphocyte proliferation 
[2] and activation of macrophages resulting in the 
release of prostaglandins [3], interleukin-1 [4], 
colony-stimulating factor [5], tumour necrosis fac- 
tor [6] and neutral proteases [7]. Most of these ef- 
fects are attributed to the lipid A part of the 
molecule [8]. 
The phorbol ester TPA also has broad biological 
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activity and elicits responses omewhat similar to 
those of lipid A [9]. Protein kinase C is a Ca2+/PS- 
dependent protein kinase of ubiquitous distribu- 
tion. Its stimulation by Ca2+ and PS can be poten- 
tiated by the addition of low concentrations of 
diacylglycerol or phorbol esters. Phorbol esters 
have been shown to substitute for diglyceride in the 
activation of protein kinase C, enhancing its affini- 
ty for Ca2+ and phospholipid [lo]. LPS was also 
shown to stimulate PI turnover [ll]. 
The role of protein kinase C in stimulus- 
response coupling has been demonstrated for a 
wide variety of cellular functions, including activa- 
tion of platelets, neutrophils, and lymphocytes in 
the inflammation and immune systems [12]. Since 
this enzyme is clearly a part of one of two well- 
known pathways to the transduction of ex- 
tracellular signals into the cells [12], the 
mechanism of some of the biological responses of 
cells exposed to LPS/lipid A might involve this en- 
zyme. Wightman and Raetz [13] recently showed 
that lipid X and precursor IVA stimulated the pro- 
tein kinase C of macrophage origin. Using purified 
protein kinase C obtained from mammalian brain, 
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we have now examined how its activation by lipid 
A, PS and phorbol esters is related. We shall show 
that lipid A does not compete for the phorbol ester 
binding site and appears to substitute for PS in the 
activation of protein kinase C. 
2. MATERIALS AND METHODS 
a column of phenylsepharose (20 ml) equilibrated 
in the last buffer including 1.5 M NaCl. The col- 
umn was washed with 50 ml of the same buffer 
and the enzyme eluted by decreasing the salt con- 
centration stepwise. The major peak was concen- 
trated by vacuum dialysis and stored in 40% 
glycerol/O.lolo Triton X-100 at - 14°C. 
2.1. Preparation of MPLA, DPLA and precursor 2.3. Protein kinase C assay 
lipid WA 
The hexaacyl form of MPLA and DPLA were 
prepared from the Re-LPS obtained from 
Salmonella minnesota R595 as described [ 14,151. 
Precursor lipid IVA was isolated and purified from 
cells of the KdsA mutant of Salmonella 
typhimurium strain i50 as in [16]. 
2.2. Purification of protein kinase C 
The enzyme was partially purified from frozen 
rabbit brain to remove contaminating protein 
kinase activity. The methods of Wolf et al. [17] 
and Parker et al. [18] were adopted. This involves 
removing other Ca *+-dependent kinases by initial 
centrifugation in a Ca*+ buffer, followed by 
DEAE ion-exchange chromatography. This is 
followed by hydrophobic interaction chromatog- 
raphy on phenyl-Sepharose: 
The enzyme was assayed at 30°C for 10 min, by 
measuring transfer of ‘*P from [32P]ATP to 
histone type III-S. The reaction was initiated by 
addition of 5 ,~l [32P]ATP (50-500 cpm/pmol) to 
a total volume of 40~1 containing (i) 12.5 mM 
MgCb; (ii) 1.5 mM CaC12; (iii) 0.625 mg/ml 
histone III-S; (iv) 0.03 mg/ml PS, and (v) 5 pl en- 
zyme. The reaction was terminated by spotting the 
reaction mixture onto Whatman phosphocellulose 
paper, washing the papers six times in tap water, 
rinsing in acetone and drying. The 32P incorpora- 
tion into histone was measured by liquid scintilla- 
tion counting. 
l-4 brains were homogenised in a Polytron in 
5 vols buffer C (20 mM Tris-HCI, pH 7.5 (25”(Z), 
50 mM 2-mercaptoethanol) with the addition of 
1 mM CaC12. The homogenate was centrifuged for 
30 min at 40000 x g. The pellet, containing 
membrane-bound enzyme, was washed and 
homogenised in the same buffer containing 
0.1 mM CaCl2 and centrifuged as before. The final 
pellet was suspended in 5 vols buffer C to which 
5 mM EGTA and 2 mM EDTA were added. This 
minimises binding of enzyme to membranes. The 
homogenate was incubated at 4°C for 1 h, and 
centrifuged at 40000 x g for 1 h. 
The activation of protein kinase C was measured 
in an identical assay after substitution of PS with 
varying concentrations of lipid A precursors. The 
suspensions of lipid A precursors and PS were 
prepared by sonication of solutions (X- Y mg/ml 
in chloroform/methanol, 95 : 5) with 20 mM Tris- 
HCl. 1 vol. of solution in chloroform/methanol 
was sonicated with 4 vols aqueous buffer for 
3 min. This was diluted IO-fold in the same Tris 
buffer by brief sonication. 
2.4. [3H]Phorbol dibutyrate binding assay 
The resulting supernatant containing cytosolic 
protein kinase C was loaded onto 50 ml DEAE 
equilibrated in buffer C containing 2 mM EDTA, 
5 mM EGTA. The column was washed with 
100 ml of the same solution, and then with 100 ml 
buffer C containing 1 mM EDTA, 1 mM EGTA. 
The enzyme was eluted with 2 x 150 ml linear salt 
gradients (O-O.4 mM NaCI) established in this buf- 
fer. The fractions, containing protein kinase C, 
were pooled, made 1.5 M in NaCl and applied to 
High-affinity binding of phorbol ester to 
specific sites can be demonstrated using 
[3H]PDBu. Protein kinase C (0.5-l pmol) was 
added to the reaction mixture containing, in a total 
volume of 200 pl, (i) 40 mM [3H]PDBu, diluted in 
20 mM Tris-HCI, pH 7.5 (25°C); (ii) 1 mM CaClz; 
(iii) 20 mM Tris-HCI, pH 7.5 (25°C); (iv) 
O-150 pg/ml PS; (v) 1 mg/ml bovine serum 
albumin, and (vi) 0.05 mM PDBu for non-specific 
binding (control). 
Incubations were carried out at room 
temperature for 15 min. This was followed by in- 
cubation for 15 min at 4°C in the presence of 
500~1 of a 30% suspension of DEAE-cellulose in 
10 mM Tris-HCl, pH 7.5 (25°C). This was ‘ter- 
minated by rapid filtration on G-FB filters 
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(2.5 cm). The filters were washed with 3 x 3 ml of 
10 mM Tris-HCl, pH 7.5 (25”C)/l mM CaClz at 
4°C; protein kinase activity was completely bound 
to the DEAE under these conditions. 
The extent of phorbol ester binding was deter- 
mined by placing the filter in 4 ml scintillant and 
measuring by liquid scintillation counting (LKB 
Rackbeta). PS was substituted with varying con- 
centrations of each lipid A precursor to determine 
their effect on [3H]PDBu binding. 
3. RESULTS AND DISCUSSION 
3.1. Activation of protein kinase C by lipid A 
(MPLA and DPLA) and disaccharide 
precursor lipid A (IVA) 
Wightman and Raetz [ 131 previously showed a 
phospholipid-independent activation of protein 
kinase C obtained from RAW 264.7 macrophages 
by crude lipid A, lipid X (monosaccharide precur- 
sor) and IVA (disaccharide precursor). All of these 
lipids have the acidic phospholipid structural 
characteristics (see fig.1 and [13]). We have now 
examined the effect of highly purified MPLA, 
DPLA and IVA on the activation of purified pro- 
tein kinase C obtained from rabbit brain and ob- 
tained similar results. Fig.2 shows that MPLA, 
DPLA and IVA all stimulated protein kinase C ac- 
tivity in a concentration-dependent manner, to 
yield increases above the basal level of 142, 118 
RI R2 R3 R4 R5 
IT A OHCI4 OHCI4 OHCI4 OHC,4 POJH~ 
MPLA C14W4 C120C14 OH’?4 OH’?4 H 
DPLA 1 C140C14 C12OCi4 OHCj4 OHC,4 P03Hz 
Fig.1. Structure of lipid A and precursor used in the 
study of activation of protein kinase C. OHC14, 
hydroxymyristate; c14oc14, myristoxymyristate; 
C120Cr4, lauroxymyristate; POsH2, phosphate. 
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Fig.2. Concentration-dependent activation of protein 
kinase C with MPLA, DPLA and precursor WA. 
and 177%, respectively, at the 150 pg level. This 
compares with a 310% increase in the enzyme ac- 
tivity for PS. Thus, the increase in the protein 
kinase C activity with these three lipids was 
somewhat similar and only modest (about one- 
half) when compared to that of PS. The disac- 
charide lipid A does not require the presence of the 
reducing-end phosphate or the acyloxyacyl-linked 
normal fatty acids for activation of this enzyme. 
Previously, Wightman and Raetz [13] showed that 
the monosaccharide lipid X was slightly more ac- 
tive than IVA in their system, indicating that the 
minimal structural requirement for activation of 
protein kinase C activity is the single structure of 
lipid X. 
3.2. Phorbol ester augmentation of protein kinase 
C stimulated by MPLA, DPLA and IVA 
Low concentration of diglyceride is known to 
augment the phospholipid stimulation of protein 
kinase C [ 171. Wightman and Raetz [ 131 in fact 
found that when diolein was combined with lipid 
X, there was a marked further stimulation of 
macrophage protein kinase C activity. We have ex- 
amined the possibility that TPA might similarly 
augment he lipid A stimulation of purified rabbit 
brain protein kinase C. As shown in fig.3, when 
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Fig.3. Augmentation of MPLA, DPLA and precursor 
IVA stimulation of protein kinase C by TPA. 
TPA was combined with MPLA, DPLA or IVA 
the activation of purified enzyme was greatly 
stimulated. This was especially striking for the 
relatively non-toxic MPLA [19] which increased 
4-fold over the initial activation level. 
3.3. Enhanced activity of protein kinase C to bind 
[-HJPDBu with increasing concentrations of 
MPLA, DPLA, and IVA 
As shown in fig.4, [3H]PDBu and lipid 
A/precursor did not compete for the same binding 
site on the enzyme. Instead, increasing concentra- 
tions of the lipid A/precursor (O-100 pug) were 
shown to enhance binding of phorbol ester to pro- 
tein kinase C in a similar manner to PS. This pro- 
vides additional evidence that the lipid A 
derivatives are substituting for PS in the activation 
of protein kinase C. The compounds tested reveal- 
ed an identical order of potency in stimulation of 
kinase C activity and in the PDBu binding assay 
(figs 2,4). 
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Fig.4. Activation of [3H]PDBu binding to protein kinase 
C by MPLA, DPLA and precursor IVA. 
relatively abundant rabbit brain enzyme. We also 
used highly purified MPLA, DPLA and IVA, 
which gave us large variations in the precisely 
known structures. Thus, structure to biological ac- 
tivity relationships could be deduced from our 
study. As indicated in [ 131, the simplest lipid 
A/precursor structure is adequate for the activa- 
tion of protein kinase C. The mechanism for 
cellular uptake of lipid A/precursors is as yet 
unknown. 
Lipid A activates protein kinase C by 
substituting for PS. We have shown here that this 
effect is additive to stimulation by TPA. The role 
of this,activation in the numerous biological ef- 
fects of LPS/lipid A remains to be determined. 
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